RE:RE:RE:RE:RE:May will be better than April There is no sudden requirement for Aristotle to be prescribed in any other way than the other tests. All we know is that FDA gives the 'lab allowance'.
The whole discussion about a test being economical is reimbursement.
The latter might be given via different channels - that is important IMHO.
CoC (the new sub) is a telehealth company as well!
So Tripp needs to take care that Aristotle can be reimbursed
one way or the other for each country.
In the US, it helps to get good reviews and usually they decide per test!
Reimbursement of Aristotle will be a game changer here!